|
1.
|
Sarkar S, Faller DV. Telomere-Homologous G-Rich Oligonucleotides Sensitize Human Ovarian Cancer Cells to TRAIL-Induced Growth Inhibition and Apoptosis. Nucleic Acid Ther. 2013 Jun; 23(3):167-74.
|
|
|
|
|
2.
|
Moore RL, Faller DV. SIRT1 represses estrogen-signaling, ligand-independent ERa-mediated transcription, and cell proliferation in estrogen-responsive breast cells. J Endocrinol. 2013; 216(3):273-85.
|
|
|
|
|
3.
|
Takashima A, Faller DV. Targeting the RAS oncogene. Expert Opin Ther Targets. 2013 May; 17(5):507-31.
|
|
|
|
|
4.
|
Lovaas JD, Zhu L, Chiao CY, Byles V, Faller DV, Dai Y. SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells. Prostate. 2013 Apr; 73(5):522-30.
|
|
|
|
|
5.
|
Steliou K, Boosalis MS, Perrine SP, Sangerman J, Faller DV. Butyrate histone deacetylase inhibitors. Biores Open Access. 2012 Aug; 1(4):192-8.
|
|
|
|
|
6.
|
Rankin AM, Sarkar S, Faller DV. Mechanism of T-oligo-induced cell cycle arrest in Mia-Paca pancreatic cancer cells. J Cell Physiol. 2012 Jun; 227(6):2586-94.
|
|
|
|
|
7.
|
Ghosh SK, Perrine SP, Faller DV. Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies. Adv Virol. 2012; 2012:509296.
|
|
|
|
|
8.
|
Byles V, Zhu L, Lovaas JD, Chmilewski LK, Wang J, Faller DV, Dai Y. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene. 2012 Oct 25; 31(43):4619-29.
|
|
|
|
|
9.
|
Moore RL, Dai Y, Faller DV. Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer. J Endocrinol. 2012 Apr; 213(1):37-48.
|
|
|
|
|
10.
|
Ghosh SK, Perrine SP, Williams RM, Faller DV. Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood. 2012 Jan 26; 119(4):1008-17.
|
|
|
|
|
11.
|
Chen Z, Forman LW, Miller KA, English B, Takashima A, Bohacek RA, Williams RM, Faller DV. Protein kinase Cd inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumors. Endocr Relat Cancer. 2011; 18(6):759-71.
|
|
|
|
|
12.
|
Sarkar S, Abujamra AL, Loew JE, Forman LW, Perrine SP, Faller DV. Histone Deacetylase Inhibitors Reverse CpG Methylation by Regulating DNMT1 through ERK Signaling. Anticancer Res. 2011 Sep; 31(9):2723-32.
|
|
|
|
|
13.
|
Boosalis MS, Castaneda SA, Trudel M, Mabaera R, White GL, Lowrey CH, Emery DW, Mpollo MS, Shen L, Wargin WA, Bohacek R, Faller DV, Perrine SP. Novel therapeutic candidates, identified by molecular modeling, induce ?-globin gene expression in vivo. Blood Cells Mol Dis. 2011 Aug 15; 47(2):107-16.
|
|
|
|
|
14.
|
Perrine SP, Wargin WA, Boosalis MS, Wallis WJ, Case S, Keefer JR, Faller DV, Welch WC, Berenson RJ. Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain Fatty Acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers. J Clin Pharmacol. 2011 Aug; 51(8):1186-94.
|
|
|
|
|
15.
|
Sarkar S, Faller DV. T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells. Oligonucleotides. 2011 Feb; 21(1):47-53.
|
|
|
|
|
16.
|
Lambert JR, Eddy VJ, Young CD, Persons KS, Sarkar S, Kelly JA, Genova E, Lucia MS, Faller DV, Ray R. A Vitamin D Receptor-Alkylating Derivative of 1{alpha},25-Dihydroxyvitamin D3 Inhibits Growth of Human Kidney Cancer Cells and Suppresses Tumor Growth. Cancer Prev Res (Phila). 2010 Dec; 3(12):1596-607.
|
|
|
|
|
17.
|
McMahon L, Tamary H, Askin M, Adams-Graves P, Eberhardt RT, Sutton M, Wright EC, Castaneda SA, Faller DV, Perrine SP. A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers. Br J Haematol. 2010 Dec; 151(5):516-24.
|
|
|
|
|
18.
|
Byles V, Chmilewski LK, Wang J, Zhu L, Forman LW, Faller DV, Dai Y. Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signaling in human cancer cells. Int J Biol Sci. 2010; 6(6):599-612.
|
|
|
|
|
19.
|
Perrine SP, Castaneda SA, Chui DH, Faller DV, Berenson RJ, Siritanaratku N, Fucharoen S. Fetal globin gene inducers: novel agents and new potential. Ann N Y Acad Sci. 2010 Aug; 1202:158-64.
|
|
|
|
|
20.
|
Zhang B, Faller DV, Wang S. HIC1 regulates tumor cell responses to endocrine therapies. Mol Endocrinol. 2009 Dec; 23(12):2075-85.
|
|
|
|
|
21.
|
Romesser PB, Perlman DH, Faller DV, Costello CE, McComb ME, Denis GV. Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma. Am J Pathol. 2009 Jul; 175(1):25-35.
|
|
|
|
|
22.
|
Forman LW, Pal-Ghosh R, Spanjaard RA, Faller DV, Ghosh SK. Identification of LTR-specific small non-coding RNA in FeLV infected cells. FEBS Lett. 2009 Apr 17; 583(8):1386-90.
|
|
|
|
|
23.
|
Perrine SP, Mankidy R, Boosalis MS, Bieker JJ, Faller DV. Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activator and is required for gamma-globin gene induction by short-chain fatty acid derivatives. Eur J Haematol. 2009 Jun; 82(6):466-76.
|
|
|
|
|
24.
|
Longe HO, Romesser PB, Rankin AM, Faller DV, Eller MS, Gilchrest BA, Denis GV. Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer. 2009 Jan 15; 124(2):473-82.
|
|
|
|
|
25.
|
Xia S, Chen Z, Forman LW, Faller DV. PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1. Cell Signal. 2009 Apr; 21(4):502-8.
|
|
|
|
|
26.
|
Zhang B, Chambers KJ, Leprince D, Faller DV, Wang S. Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control. Oncogene. 2009 Feb 5; 28(5):651-61.
|
|
|
|
|
27.
|
Wang L, Persons KS, Jamieson D, Flanagan JN, Hsu HH, Holick MF, Luo Z, Sakaki T, Urushino N, Faller DV, Chen TC. Prostate 25-hydroxyvitamin D-1alpha-hydroxylase is up-regulated by suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor. Anticancer Res. 2008 Jul-Aug; 28(4A):2009-13.
|
|
|
|
|
28.
|
Dai Y, Ngo D, Jacob J, Forman LW, Faller DV. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes. Carcinogenesis. 2008 Sep; 29(9):1725-33.
|
|
|
|
|
29.
|
Dai Y, Faller DV. Transcription Regulation by Class III Histone Deacetylases (HDACs)-Sirtuins. Transl Oncogenomics. 2008; 3:53-65.
|
|
|
|
|
30.
|
Rankin AM, Faller DV, Spanjaard RA. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity. Anticancer Drugs. 2008 Apr; 19(4):329-38.
|
|
|
|
|
31.
|
Florence BL, Faller DV. Drosophila female sterile (1) homeotic is a multifunctional transcriptional regulator that is modulated by Ras signaling. Dev Dyn. 2008 Mar; 237(3):554-64.
|
|
|
|
|
32.
|
Wang S, Faller DV. Roles of prohibitin in growth control and tumor suppression in human cancers. Transl Oncogenomics. 2008; 3:23-37.
|
|
|
|
|
33.
|
Mork CN, Faller DV, Spanjaard RA. Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide. FEBS Lett. 2007 Nov 27; 581(28):5440-4.
|
|
|
|
|
34.
|
Pan H, Gao F, Papageorgis P, Abdolmaleky HM, Faller DV, Thiagalingam S. Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progression. Cancer Biol Ther. 2007 Oct; 6(10):1638-43.
|
|
|
|
|
35.
|
Dai Y, Ngo D, Forman LW, Qin DC, Jacob J, Faller DV. Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Mol Endocrinol. 2007 Aug; 21(8):1807-21.
|
|
|
|
|
36.
|
Zhang B, Chambers KJ, Faller DV, Wang S. Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation. Oncogene. 2007 Nov 1; 26(50):7153-7.
|
|
|
|
|
37.
|
Panasyuk SV, Yang S, Faller DV, Ngo D, Lew RA, Freeman JE, Rogers AE. Medical hyperspectral imaging to facilitate residual tumor identification during surgery. Cancer Biol Ther. 2007 Mar; 6(3):439-46.
|
|
|
|
|
38.
|
Xia S, Forman LW, Faller DV. Protein kinase C delta is required for survival of cells expressing activated p21RAS. J Biol Chem. 2007 May 4; 282(18):13199-210.
|
|
|
|
|
39.
|
Lenburg ME, Sinha A, Faller DV, Denis GV. Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis. J Biol Chem. 2007 Feb 16; 282(7):4803-11.
|
|
|
|
|
40.
|
Ghosh SK, Forman LW, Akinsheye I, Perrine SP, Faller DV. Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents. Blood Cells Mol Dis. 2007 Jan-Feb; 38(1):57-65.
|
|
|
|
|
41.
|
Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV. A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood. 2007 Mar 15; 109(6):2571-8.
|
|
|
|
|
42.
|
Mankidy R, Faller DV, Mabaera R, Lowrey CH, Boosalis MS, White GL, Castaneda SA, Perrine SP. Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex. Blood. 2006 Nov 1; 108(9):3179-86.
|
|
|
|
|
43.
|
Bohacek R, Boosalis MS, McMartin C, Faller DV, Perrine SP. Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models. Chem Biol Drug Des. 2006 May; 67(5):318-28.
|
|
|
|
|
44.
|
Denis GV, McComb ME, Faller DV, Sinha A, Romesser PB, Costello CE. Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. J Proteome Res. 2006 Mar; 5(3):502-11.
|
|
|
|
|
45.
|
Ghez D, Damotte D, Perrine SP, Faller DV, Canioni D, Brousse N, Lefrère F, Varet B, Hermine O. Fas ligand-mediated lethal hepatitis after rapid lysis of a localized natural killer cell lymphoma. Clin Lymphoma Myeloma. 2006 Mar; 6(5):417-9.
|
|
|
|
|
46.
|
Abujamra AL, Spanjaard RA, Akinsheye I, Zhao X, Faller DV, Ghosh SK. Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism. Virology. 2006 Feb 20; 345(2):390-403.
|
|
|
|
|
47.
|
Castaneda S, Boosalis MS, Emery D, Thies A, Faller DV, Perrine SP. Enhancement of growth and survival and alterations in Bcl-family proteins in beta-thalassemic erythroid progenitors by novel short-chain fatty acid derivatives. Blood Cells Mol Dis. 2005 Sep-Oct; 35(2):217-26.
|
|
|
|
|
48.
|
Sinha A, Faller DV, Denis GV. Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. Biochem J. 2005 Apr 1; 387(Pt 1):257-69.
|
|
|
|
|
49.
|
Mork CN, Faller DV, Spanjaard RA. A mechanistic approach to anticancer therapy: targeting the cell cycle with histone deacetylase inhibitors. Curr Pharm Des. 2005; 11(9):1091-104.
|
|
|
|
|
50.
|
Chen JS, Faller DV. Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. J Cell Physiol. 2005 Jan; 202(1):87-99.
|
|
|
|
|
51.
|
Wang S, Zhang B, Faller DV. BRG1/BRM and prohibitin are required for growth suppression by estrogen antagonists. EMBO J. 2004 Jun 2; 23(11):2293-303.
|
|
|
|
|
52.
|
Liou JS, Chen JS, Faller DV. Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines. J Cell Physiol. 2004 Feb; 198(2):277-94.
|
|
|
|
|
53.
|
Greenwald RJ, Tumang JR, Sinha A, Currier N, Cardiff RD, Rothstein TL, Faller DV, Denis GV. E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. Blood. 2004 Feb 15; 103(4):1475-84.
|
|
|
|
|
54.
|
Chen JS, Faller DV, Spanjaard RA. Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? Curr Cancer Drug Targets. 2003 Jun; 3(3):219-36.
|
|
|
|
|
55.
|
Abujamra AL, Faller DV, Ghosh SK. Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication. Virology. 2003 May 10; 309(2):294-305.
|
|
|
|
|
56.
|
van de Mark K, Chen JS, Steliou K, Perrine SP, Faller DV. Alpha-lipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines. J Cell Physiol. 2003 Mar; 194(3):325-40.
|
|
|
|
|
57.
|
Denis GV, Yu Q, Ma P, Deeds L, Faller DV, Chen CY. Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras. J Biol Chem. 2003 Feb 21; 278(8):5775-85.
|
|
|
|
|
58.
|
Park JH, Faller DV. Epstein-Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation. Virology. 2002 Nov 25; 303(2):345-63.
|
|
|
|
|
59.
|
Ma P, Magut M, Faller DV, Chen CY. The role of Ras in T lymphocyte activation. Cell Signal. 2002 Oct; 14(10):849-59.
|
|
|
|
|
60.
|
Pace BS, White GL, Dover GJ, Boosalis MS, Faller DV, Perrine SP. Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood. 2002 Dec 15; 100(13):4640-8.
|
|
|
|
|
61.
|
Wang S, Zhang B, Faller DV. Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth. EMBO J. 2002 Jun 17; 21(12):3019-28.
|
|
|
|
|
62.
|
Stice LL, Forman LW, Hahn CS, Faller DV. Desensitization of the PDGFbeta receptor by modulation of the cytoskeleton: the role of p21(Ras) and Rho family GTPases. Exp Cell Res. 2002 Apr 15; 275(1):17-30.
|
|
|
|
|
63.
|
Krishna S, Brown N, Faller DV, Spanjaard RA. Differential effects of short-chain fatty acids on head and neck squamous carcinoma cells. Laryngoscope. 2002 Apr; 112(4):645-50.
|
|
|
|
|
64.
|
Guo N, Faller DV, Vaziri C. Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive. Cell Growth Differ. 2002 Feb; 13(2):77-86.
|
|
|
|
|
65.
|
Mentzer SJ, Perrine SP, Faller DV. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate. Transpl Infect Dis. 2001 Sep; 3(3):177-85.
|
|
|
|
|
66.
|
Faller DV, Mentzer SJ, Perrine SP. Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies. Curr Opin Oncol. 2001 Sep; 13(5):360-7.
|
|
|
|
|
67.
|
Florence B, Faller DV. You bet-cha: a novel family of transcriptional regulators. Front Biosci. 2001 Aug 1; 6:D1008-18.
|
|
|
|
|
68.
|
Demary K, Wong L, Liou JS, Faller DV, Spanjaard RA. Redox control of retinoic acid receptor activity: a novel mechanism for retinoic acid resistance in melanoma cells. Endocrinology. 2001 Jun; 142(6):2600-5.
|
|
|
|
|
69.
|
Chen CY, Juo P, Liou JS, Li CQ, Yu Q, Blenis J, Faller DV. The recruitment of Fas-associated death domain/caspase-8 in Ras-induced apoptosis. Cell Growth Differ. 2001 Jun; 12(6):297-306.
|
|
|
|
|
70.
|
Boosalis MS, Bandyopadhyay R, Bresnick EH, Pace BS, Van DeMark K, Zhang B, Faller DV, Perrine SP. Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation. Blood. 2001 May 15; 97(10):3259-67.
|
|
|
|
|
71.
|
Lynch EM, Moreland RB, Ginis I, Perrine SP, Faller DV. Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. Am J Physiol Cell Physiol. 2001 Apr; 280(4):C897-911.
|
|
|
|
|
72.
|
Liou JS, Chen CY, Chen JS, Faller DV. Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. J Biol Chem. 2000 Dec 15; 275(50):39001-11.
|
|
|
|
|
73.
|
Ghosh SK, Roy-Burman P, Faller DV. Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression. J Virol. 2000 Oct; 74(20):9742-8.
|
|
|
|
|
74.
|
Guo N, Faller DV, Denis GV. Activation-induced nuclear translocation of RING3. J Cell Sci. 2000 Sep; 113 ( Pt 17):3085-91.
|
|
|
|
|
75.
|
Hsing A, Faller DV, Vaziri C. DNA-damaging aryl hydrocarbons induce Mdm2 expression via p53-independent post-transcriptional mechanisms. J Biol Chem. 2000 Aug 25; 275(34):26024-31.
|
|
|
|
|
76.
|
Denis GV, Vaziri C, Guo N, Faller DV. RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. Cell Growth Differ. 2000 Aug; 11(8):417-24.
|
|
|
|
|
77.
|
Ginis I, Faller DV. Hypoxia affects tumor cell invasiveness in vitro: the role of hypoxia-activated ligand HAL1/13 (Ku86 autoantigen). Cancer Lett. 2000 Jun 30; 154(2):163-74.
|
|
|
|
|
78.
|
Guo N, Faller DV, Vaziri C. A novel DNA damage checkpoint involving post-transcriptional regulation of cyclin A expression. J Biol Chem. 2000 Jan 21; 275(3):1715-22.
|
|
|
|
|
79.
|
Ghosh SK, Faller DV. Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1. J Virol. 1999 Jun; 73(6):4931-40.
|
|
|
|
|
80.
|
Chen CY, Faller DV. Selective inhibition of protein kinase C isozymes by Fas ligation. J Biol Chem. 1999 May 28; 274(22):15320-8.
|
|
|
|
|
81.
|
Atweh GF, Sutton M, Nassif I, Boosalis V, Dover GJ, Wallenstein S, Wright E, McMahon L, Stamatoyannopoulos G, Faller DV, Perrine SP. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood. 1999 Mar 15; 93(6):1790-7.
|
|
|
|
|
82.
|
Stice LL, Vaziri C, Faller DV. Regulation of platelet-derived growth factor signaling by activated p21Ras. Front Biosci. 1999 Jan 15; 4:D72-86.
|
|
|
|
|
83.
|
Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol. 1999 Jan; 26(1):74-84.
|
|
|
|
|
84.
|
Bandyopadhyay RS, Faller DV. Establishment of order in the flow of genetic information in cells. Cell Biochem Biophys. 1999; 30(1):35-70.
|
|
|
|
|
85.
|
Phelan MW, Forman LW, Perrine SP, Faller DV. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. J Lab Clin Med. 1998 Dec; 132(6):519-29.
|
|
|
|
|
86.
|
Chen CY, Liou J, Forman LW, Faller DV. Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras. Cell Death Differ. 1998 Nov; 5(11):984-95.
|
|
|
|
|
87.
|
Ikuta T, Kan YW, Swerdlow PS, Faller DV, Perrine SP. Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy. Blood. 1998 Oct 15; 92(8):2924-33.
|
|
|
|
|
88.
|
Chen CY, Liou J, Forman LW, Faller DV. Differential regulation of discrete apoptotic pathways by Ras. J Biol Chem. 1998 Jul 3; 273(27):16700-9.
|
|
|
|
|
89.
|
Ikuta T, Atweh G, Boosalis V, White GL, Da Fonseca S, Boosalis M, Faller DV, Perrine SP. Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis. Ann N Y Acad Sci. 1998 Jun 30; 850:87-99.
|
|
|
|
|
90.
|
Mentzer SJ, Fingeroth J, Reilly JJ, Perrine SP, Faller DV. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma. Blood Cells Mol Dis. 1998 Jun; 24(2):114-23.
|
|
|
|
|
91.
|
Vaziri C, Stice L, Faller DV. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals. Cell Growth Differ. 1998 Jun; 9(6):465-74.
|
|
|
|
|
92.
|
Boosalis MS, Ikuta T, Pace BS, da Fonseca S, White GL, Faller DV, Perrine SP. Abrogation of IL-3 requirements and stimulation of hematopoietic cell proliferation in vitro and in vivo by carboxylic acids. Blood Cells Mol Dis. 1997 Dec; 23(3):434-42.
|
|
|
|
|
93.
|
Faller DV, Weng H, Graves DT, Choi SY. Moloney murine leukemia virus long terminal repeat activates monocyte chemotactic protein-1 protein expression and chemotactic activity. J Cell Physiol. 1997 Aug; 172(2):240-52.
|
|
|
|
|
94.
|
Choi SY, van de Mark K, Faller DV. Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences. J Virol. 1997 Feb; 71(2):965-70.
|
|
|
|
|
95.
|
Rosenberg CL, Larson PS, Romo JD, De Las Morenas A, Faller DV. Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer. Hum Pathol. 1997 Feb; 28(2):214-9.
|
|
|
|
|
96.
|
Vaziri C, Faller DV. A benzo[a]pyrene-induced cell cycle checkpoint resulting in p53-independent G1 arrest in 3T3 fibroblasts. J Biol Chem. 1997 Jan 31; 272(5):2762-9.
|
|
|
|
|
97.
|
Faller DV, Weng H, Choi SY. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat. Virology. 1997 Jan 20; 227(2):331-42.
|
|
|
|
|
98.
|
Ginis I, Faller DV. Protection from apoptosis in human neutrophils is determined by the surface of adhesion. Am J Physiol. 1997 Jan; 272(1 Pt 1):C295-309.
|
|
|
|
|
99.
|
Bandyopadhyay RS, Faller DV. Regulation of c-jun gene expression in endothelial cells by the protein kinase inhibitor staurosporine. Endothelium. 1997; 5(2):95-105.
|
|
|
|
|
100.
|
Chen CY, Forman LW, Faller DV. Calcium-dependent immediate-early gene induction in lymphocytes is negatively regulated by p21Ha-ras. Mol Cell Biol. 1996 Nov; 16(11):6582-92.
|
|
|
|
|
101.
|
Vaziri C, Schneider A, Sherr DH, Faller DV. Expression of the aryl hydrocarbon receptor is regulated by serum and mitogenic growth factors in murine 3T3 fibroblasts. J Biol Chem. 1996 Oct 18; 271(42):25921-7.
|
|
|
|
|
102.
|
Comenzo RL, Vosburgh E, Simms RW, Bergethon P, Sarnacki D, Finn K, Dubrey S, Faller DV, Wright DG, Falk RH, Skinner M. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood. 1996 Oct 1; 88(7):2801-6.
|
|
|
|
|
103.
|
Rosenberg CL, de las Morenas A, Huang K, Cupples LA, Faller DV, Larson PS. Detection of monoclonal microsatellite alterations in atypical breast hyperplasia. J Clin Invest. 1996 Sep 1; 98(5):1095-100.
|
|
|
|
|
104.
|
Mentzer SJ, Longtine J, Fingeroth J, Reilly JJ, DeCamp MM, O'Donnell W, Swanson SJ, Faller DV, Sugarbaker DJ. Immunoblastic lymphoma of donor origin in the allograft after lung transplantation. Transplantation. 1996 Jun 27; 61(12):1720-5.
|
|
|
|
|
105.
|
Vaziri C, Faller DV. Down-regulation of platelet-derived growth factor receptor expression during terminal differentiation of 3T3-L1 pre-adipocyte fibroblasts. J Biol Chem. 1996 Jun 7; 271(23):13642-8.
|
|
|
|
|
106.
|
Phelan MW, Faller DV. Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. J Cell Physiol. 1996 Jun; 167(3):469-76.
|
|
|
|
|
107.
|
Pak J, Faller DV. Moloney murine leukemia virus activates NF-kappa B. J Virol. 1996 Jun; 70(6):4167-72.
|
|
|
|
|
108.
|
DeLaney TF, Afridi N, Taghian AG, Sanders DA, Fuleihan NS, Faller DV, Nogueira CP. 13-cis-retinoic acid with alpha-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro. Cancer Res. 1996 May 15; 56(10):2277-80.
|
|
|
|
|
109.
|
Zubiaur M, Forman LW, Stice LL, Faller DV. A role for activated p21 ras in inhibition/regulation of platelet-derived growth factor (PDGF) type-beta receptor activation. Oncogene. 1996 Mar 21; 12(6):1213-22.
|
|
|
|
|
110.
|
Chen CY, Faller DV. Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. J Biol Chem. 1996 Feb 2; 271(5):2376-9.
|
|
|
|
|
111.
|
Torkelson S, White B, Faller DV, Phipps K, Pantazis C, Perrine SP. Erythroid progenitor proliferation is stimulated by phenoxyacetic and phenylalkyl acids. Blood Cells Mol Dis. 1996; 22(2):150-8.
|
|
|
|
|
112.
|
Brauer M, al-Momen AK, Faller DV. Butyrate treatment in beta-hemoglobinopathies. N Engl J Med. 1995 Nov 9; 333(19):1287-8.
|
|
|
|
|
113.
|
Choi SY, Faller DV. A transcript from the long terminal repeats of a murine retrovirus associated with trans activation of cellular genes. J Virol. 1995 Nov; 69(11):7054-60.
|
|
|
|
|
114.
|
Chen CY, Faller DV. Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene. 1995 Oct 19; 11(8):1487-98.
|
|
|
|
|
115.
|
Bandyopadhyay RS, Phelan M, Faller DV. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim Biophys Acta. 1995 Oct 17; 1264(1):72-8.
|
|
|
|
|
116.
|
Phelan M, Perrine SP, Brauer M, Faller DV. Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. J Clin Invest. 1995 Aug; 96(2):1145-51.
|
|
|
|
|
117.
|
Zubiaur M, Sancho J, Terhorst C, Faller DV. A small GTP-binding protein, Rho, associates with the platelet-derived growth factor type-beta receptor upon ligand binding. J Biol Chem. 1995 Jul 21; 270(29):17221-8.
|
|
|
|
|
118.
|
Ginis I, Mentzer SJ, Li X, Faller DV. Characterization of a hypoxia-responsive adhesion molecule for leukocytes on human endothelial cells. J Immunol. 1995 Jul 15; 155(2):802-10.
|
|
|
|
|
119.
|
Weng H, Choi SY, Faller DV. The Moloney leukemia retroviral long terminal repeat trans-activates AP-1-inducible genes and AP-1 transcription factor binding. J Biol Chem. 1995 Jun 9; 270(23):13637-44.
|
|
|
|
|
120.
|
Mentzer SJ, Reilly JJ, DeCamp M, Sugarbaker DJ, Faller DV. Potential mechanism of vasomotor dysregulation after lung transplantation for primary pulmonary hypertension. J Heart Lung Transplant. 1995 Mar-Apr; 14(2):387-93.
|
|
|
|
|
121.
|
Vaziri C, Faller DV. Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts. Mol Cell Biol. 1995 Mar; 15(3):1244-53.
|
|
|
|
|
122.
|
Faller DV, Perrine SP. Butyrate in the treatment of sickle cell disease and beta-thalassemia. Curr Opin Hematol. 1995 Mar; 2(2):109-17.
|
|
|
|
|
123.
|
Mundschau LJ, Faller DV. Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J Biol Chem. 1995 Feb 17; 270(7):3100-6.
|
|
|
|
|
124.
|
Perrine SP, Dover GH, Daftari P, Walsh CT, Jin Y, Mays A, Faller DV. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo. Br J Haematol. 1994 Nov; 88(3):555-61.
|
|
|
|
|
125.
|
Li X, Abdi K, Herren T, Faller DV, Mentzer SJ. Affinity membrane identification of immunoglobulin subclass in hybridoma screening. Hybridoma. 1994 Oct; 13(5):431-5.
|
|
|
|
|
126.
|
Choi SY, Faller DV. The long terminal repeats of a murine retrovirus encode a trans-activator for cellular genes. J Biol Chem. 1994 Aug 5; 269(31):19691-4.
|
|
|
|
|
127.
|
Mundschau LJ, Forman LW, Weng H, Faller DV. Platelet-derived growth factor (PDGF) induction of egr-1 is independent of PDGF receptor autophosphorylation on tyrosine. J Biol Chem. 1994 Jun 10; 269(23):16137-42.
|
|
|
|
|
128.
|
Ginis I, Faller DV. Quantitative estimation of the degree of cell spreading on different surfaces and cell monolayers using a fluorescent plate scanner. Anal Biochem. 1994 Jun; 219(2):288-96.
|
|
|
|
|
129.
|
Faller DV, Mundschau LJ, Forman LW, Quiñones MA. v-mos suppresses platelet-derived growth factor (PDGF) type-beta receptor autophosphorylation and inhibits PDGF-BB-mediated signal transduction. J Biol Chem. 1994 Feb 18; 269(7):5022-9.
|
|
|
|
|
130.
|
Perrine SP, Olivieri NF, Faller DV, Vichinsky EP, Dover GJ, Ginder GD. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders. Am J Pediatr Hematol Oncol. 1994 Feb; 16(1):67-71.
|
|
|
|
|
131.
|
Mundschau LJ, Faller DV. Endogenous inhibitors of the dsRNA-dependent eIF-2 alpha protein kinase PKR in normal and ras-transformed cells. Biochimie. 1994; 76(8):792-800.
|
|
|
|
|
132.
|
Ginis I, Mentzer SJ, Faller DV. Oxygen tension regulates neutrophil adhesion to human endothelial cells via an LFA-1-dependent mechanism. J Cell Physiol. 1993 Dec; 157(3):569-78.
|
|
|
|
|
133.
|
Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 1993 Jul; 92(1):99-104.
|
|
|
|
|
134.
|
Ginis I, Mentzer SJ, Faller DV. Hypoxia induces lymphocyte adhesion to human mesenchymal cells via an LFA-1-dependent mechanism. Am J Physiol. 1993 Mar; 264(3 Pt 1):C617-24.
|
|
|
|
|
135.
|
Perrine SP, Faller DV. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies. Experientia. 1993 Feb 15; 49(2):133-7.
|
|
|
|
|
136.
|
Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, Cai SP, Vichinsky EP, Olivieri NF. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med. 1993 Jan 14; 328(2):81-6.
|
|
|
|
|
137.
|
Kwok RP, Cameron JL, Faller DV, Fernstrom JD. Effects of cysteamine administration on somatostatin biosynthesis and levels in rat hypothalamus. Endocrinology. 1992 Dec; 131(6):2999-3009.
|
|
|
|
|
138.
|
Mundschau LJ, Faller DV. Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2 alpha-kinase activation. J Biol Chem. 1992 Nov 15; 267(32):23092-8.
|
|
|
|
|
139.
|
Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 1991 Sep; 88(3):1054-7.
|
|
|
|
|
140.
|
Quiñones MA, Mundschau LJ, Rake JB, Faller DV. Dissociation of platelet-derived growth factor (PDGF) receptor autophosphorylation from other PDGF-mediated second messenger events. J Biol Chem. 1991 Jul 25; 266(21):14055-63.
|
|
|
|
|
141.
|
Mundschau LJ, Faller DV. BALB/c-3T3 fibroblasts resistant to growth inhibition by beta interferon exhibit aberrant platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor signal transduction. Mol Cell Biol. 1991 Jun; 11(6):3148-54.
|
|
|
|
|
142.
|
Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991 May 11; 19(9):2499.
|
|
|
|
|
143.
|
Koka P, van de Mark K, Faller DV. trans-Activation of genes encoding activation-associated human T lymphocyte surface proteins by murine retroviral sequences. J Immunol. 1991 Apr 1; 146(7):2417-25.
|
|
|
|
|
144.
|
Rake JB, Quiñones MA, Faller DV. Inhibition of platelet-derived growth factor-mediated signal transduction by transforming ras. Suppression of receptor autophosphorylation. J Biol Chem. 1991 Mar 15; 266(8):5348-52.
|
|
|
|
|
145.
|
Maziarz RT, Mentzer SJ, Burakoff SJ, Faller DV. Distinct effects of interferon-gamma and MHC class I surface antigen levels on resistance of the K562 tumor cell line to natural killer-mediated lysis. Cell Immunol. 1990 Oct 15; 130(2):329-38.
|
|
|
|
|
146.
|
Kourembanas S, Hannan RL, Faller DV. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest. 1990 Aug; 86(2):670-4.
|
|
|
|
|
147.
|
Mentzer SJ, Faller DV. Soluble and surface-bound immunoglobulin triggers human monocyte activation and hydrogen peroxide release. Exp Hematol. 1990 Aug; 18(7):812-7.
|
|
|
|
|
148.
|
Miller BA, Olivieri N, Hope SM, Faller DV, Perrine SP. Interferon-gamma modulates fetal hemoglobin synthesis in sickle cell anemia and thalassemia. J Interferon Res. 1990 Aug; 10(4):357-66.
|
|
|
|
|
149.
|
Kadison P, Poteat HT, Klein KM, Faller DV. Role of protein kinase A in tax transactivation of the human T-cell leukemia virus type I long terminal repeat. J Virol. 1990 May; 64(5):2141-8.
|
|
|
|
|
150.
|
Offermann MK, Faller DV. Effect of cellular density and viral oncogenes on the major histocompatibility complex class I antigen response to gamma-interferon in BALB-c/3T3 cells. Cancer Res. 1990 Feb 1; 50(3):601-5.
|
|
|
|
|
151.
|
Maziarz RT, Burakoff SJ, Faller DV. The regulation of exogenous and endogenous class I MHC genes in a human tumor cell line, K562. Mol Immunol. 1990 Feb; 27(2):135-42.
|
|
|
|
|
152.
|
Perrine SP, Faller DV, Swerdlow P, Miller BA, Bank A, Sytkowski AJ, Reczek J, Rudolph AM, Kan YW. Stopping the biologic clock for globin gene switching. Ann N Y Acad Sci. 1990; 612:134-40.
|
|
|
|
|
153.
|
Perrine SP, Miller BA, Faller DV, Cohen RA, Vichinsky EP, Hurst D, Lubin BH, Papayannopoulou T. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia. Blood. 1989 Jul; 74(1):454-9.
|
|
|
|
|
154.
|
Offermann MK, Faller DV. Autocrine induction of major histocompatibility complex class I antigen expression results from induction of beta interferon in oncogene-transformed BALB/c-3T3 cells. Mol Cell Biol. 1989 May; 9(5):1969-77.
|
|
|
|
|
155.
|
Kourembanas S, Faller DV. Platelet-derived growth factor production by human umbilical vein endothelial cells is regulated by basic fibroblast growth factor. J Biol Chem. 1989 Mar 15; 264(8):4456-9.
|
|
|
|
|
156.
|
Perrine SP, Vichinsky E, Faller DV. Hematopoietic hormones: from cloning to clinic. Am J Pediatr Hematol Oncol. 1989; 11(3):268-75.
|
|
|
|
|
157.
|
Perrine SP, Miller BA, Papayannopoulou T, Faller DV, Rudolph AM, Vichinsky E, Hurst D, Kan YW. Butyrate analogues modulate globin gene expression in human and ovine erythroid cells. Prog Clin Biol Res. 1989; 316B:341-50.
|
|
|
|
|
158.
|
Perrine SP, Swerdlow P, Faller DV, Qin G, Rudolph AM, Reczek J, Kan YW. Butyric acid modulates developmental globin gene switching in man and sheep. Adv Exp Med Biol. 1989; 271:177-83.
|
|
|
|
|
159.
|
Zullo JN, Faller DV. P21 v-ras inhibits induction of c-myc and c-fos expression by platelet-derived growth factor. Mol Cell Biol. 1988 Dec; 8(12):5080-5.
|
|
|
|
|
160.
|
Koka P, Yunis J, Passarelli AL, Dubey DP, Faller DV, Ynis EJ. Increased expression of CD4 molecules on Jurkat cells mediated by human immunodeficiency virus tat protein. J Virol. 1988 Nov; 62(11):4353-7.
|
|
|
|
|
161.
|
Petrarca MA, Reiss CS, Diamond DC, Boni J, Burakoff SJ, Faller DV. T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection. Microb Pathog. 1988 Nov; 5(5):319-32.
|
|
|
|
|
162.
|
Perrine SP, Rudolph A, Faller DV, Roman C, Cohen RA, Chen SJ, Kan YW. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci U S A. 1988 Nov; 85(22):8540-2.
|
|
|
|
|
163.
|
Arnaout MA, Lanier LL, Faller DV. Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific. J Cell Physiol. 1988 Nov; 137(2):305-9.
|
|
|
|
|
164.
|
Mentzer SJ, Rothlein R, Springer TA, Faller DV. Intercellular adhesion molecule-1 (ICAM-1) is involved in the cytolytic T lymphocyte interaction with a human synovial cell line. J Cell Physiol. 1988 Oct; 137(1):173-8.
|
|
|
|
|
165.
|
Sieff CA, Niemeyer CM, Mentzer SJ, Faller DV. Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells. Blood. 1988 Oct; 72(4):1316-23.
|
|
|
|
|
166.
|
Reynolds DS, Serafin WE, Faller DV, Wall DA, Abbas AK, Dvorak AM, Austen KF, Stevens RL. Immortalization of murine connective tissue-type mast cells at multiple stages of their differentiation by coculture of splenocytes with fibroblasts that produce Kirsten sarcoma virus. J Biol Chem. 1988 Sep 5; 263(25):12783-91.
|
|
|
|
|
167.
|
Faller DV, Crimmins MA, Mentzer SJ. Human T-cell leukemia virus type I infection of CD4+ or CD8+ cytotoxic T-cell clones results in immortalization with retention of antigen specificity. J Virol. 1988 Aug; 62(8):2942-50.
|
|
|
|
|
168.
|
Mentzer SJ, Herrmann SH, Crimmins MA, Burakoff SJ, Faller DV. The role of CD18 in phorbol ester-induced human monocyte-mediated cytotoxicity. Cell Immunol. 1988 Aug; 115(1):66-77.
|
|
|
|
|
169.
|
Faller DV, Wilson LD, Flyer DC. Mechanism of induction of class I major histocompatibility antigen expression by murine leukemia virus. J Cell Biochem. 1988 Mar; 36(3):297-309.
|
|
|
|
|
170.
|
Perrine SP, Greene MF, Cohen RA, Faller DV. A physiological delay in human fetal hemoglobin switching is associated with specific globin DNA hypomethylation. FEBS Lett. 1988 Feb 8; 228(1):139-43.
|
|
|
|
|
171.
|
Hannan RL, Kourembanas S, Flanders KC, Rogelj SJ, Roberts AB, Faller DV, Klagsbrun M. Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors. 1988; 1(1):7-17.
|
|
|
|
|
172.
|
Faller DV, Kourembanas S, Ginsberg D, Hannan R, Collins T, Ewenstein BM, Pober JS, Tantravahi R. Immortalization of human endothelial cells by murine sarcoma viruses, without morphologic transformation. J Cell Physiol. 1988 Jan; 134(1):47-56.
|
|
|
|
|
173.
|
Perrine SP, Miller BA, Greene MF, Cohen RA, Cook N, Shackleton C, Faller DV. Butryic acid analogues augment gamma globin gene expression in neonatal erythroid progenitors. Biochem Biophys Res Commun. 1987 Oct 29; 148(2):694-700.
|
|
|
|
|
174.
|
Wilson LD, Flyer DC, Faller DV. Murine retroviruses control class I major histocompatibility antigen gene expression via a trans effect at the transcriptional level. Mol Cell Biol. 1987 Jul; 7(7):2406-15.
|
|
|
|
|
175.
|
Miller BA, Perrine SP, Antognetti G, Perlmutter DH, Emerson SG, Sieff C, Faller DV. Gamma-interferon alters globin gene expression in neonatal and adult erythroid cells. Blood. 1987 Jun; 69(6):1674-81.
|
|
|
|
|
176.
|
Lichtman AH, Williams ME, Ohara J, Paul WE, Faller DV, Abbas AK. Retrovirus infection alters growth factor responses of T lymphocytes. J Immunol. 1987 May 15; 138(10):3276-83.
|
|
|
|
|
177.
|
Mentzer SJ, Crimmins MA, Burakoff SJ, Faller DV. Alpha and beta subunits of the LFA-1 membrane molecule are involved in human monocyte-endothelial cell adhesion. J Cell Physiol. 1987 Mar; 130(3):410-5.
|
|
|
|
|
178.
|
Sieff CA, Tsai S, Faller DV. Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor. J Clin Invest. 1987 Jan; 79(1):48-51.
|
|
|
|
|
179.
|
Sieff CA, Niemeyer CM, Faller DV. The role of endothelial cells in hematopoiesis. Prog Clin Biol Res. 1987; 251:13-21.
|
|
|
|
|
180.
|
Ballmer-Hofer K, Mandel G, Faller DV, Roberts TM, Benjamin TL. Expression of influenza hemagglutinin-polyoma T-antigen fusion proteins in a rat embryo fibroblast cell line. Virus Res. 1987 Jan; 6(4):345-61.
|
|
|
|
|
181.
|
Perrine S, Kan YW, Greene MF, Rubin E, Cooper S, Cohen R, Roman C, Rudolph A, Faller DV. Inhibition of fetal globin gene switching in vivo in human and ovine fetuses. Prog Clin Biol Res. 1987; 251:545-54.
|
|
|
|
|
182.
|
Flyer DC, Burakoff SJ, Faller DV. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens. J Immunol. 1986 Dec 15; 137(12):3968-72.
|
|
|
|
|
183.
|
Lichtman AH, Reynolds DS, Faller DV, Abbas AK. Mature murine B lymphocytes immortalized by Kirsten sarcoma virus. Nature. 1986 Dec 4-10; 324(6096):489-91.
|
|
|
|
|
184.
|
Perrine SP, Greene MF, Lee PD, Cohen RA, Faller DV. Insulin stimulates cord blood erythroid progenitor growth: evidence for an aetiological role in neonatal polycythaemia. Br J Haematol. 1986 Nov; 64(3):503-11.
|
|
|
|
|
185.
|
Mentzer SJ, Guyre PM, Burakoff SJ, Faller DV. Spontaneous aggregation as a mechanism for human monocyte purification. Cell Immunol. 1986 Sep; 101(2):312-9.
|
|
|
|
|
186.
|
Mentzer SJ, Faller DV, Burakoff SJ. Interferon-gamma induction of LFA-1-mediated homotypic adhesion of human monocytes. J Immunol. 1986 Jul 1; 137(1):108-13.
|
|
|
|
|
187.
|
Mentzer SJ, Burakoff SJ, Faller DV. Adhesion of T lymphocytes to human endothelial cells is regulated by the LFA-1 membrane molecule. J Cell Physiol. 1986 Feb; 126(2):285-90.
|
|
|
|
|
188.
|
Flyer DC, Burakoff SJ, Faller DV. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. J Immunol. 1985 Oct; 135(4):2287-92.
|
|
|
|
|
189.
|
Perrine SP, Greene MF, Faller DV. Delay in the fetal globin switch in infants of diabetic mothers. N Engl J Med. 1985 Feb 7; 312(6):334-8.
|
|
|
|
|
190.
|
Flyer DC, Burakoff SJ, Faller DV. Expression and CTL recognition of cloned subgenomic fragments of Moloney murine leukemia virus in murine cells. Surv Immunol Res. 1985; 4(2):168-72.
|
|
|
|
|
191.
|
Faller DV, Baltimore D. Liposome encapsulation of retrovirus allows efficient superinfection of resistant cell lines. J Virol. 1984 Jan; 49(1):269-72.
|
|
|
|
|
192.
|
Flyer DC, Burakoff SJ, Faller DV. Cytotoxic T lymphocyte recognition of transfected cells expressing a cloned retroviral gene. Nature. 1983 Oct 27-Nov 2; 305(5937):815-8.
|
|
|
|
|
193.
|
Faller DV, Hopkins N. T1 oligonucleotide maps of Moloney and HIX murine leukemia viruses. Virology. 1978 Oct 15; 90(2):265-73.
|
|
|
|
|
194.
|
Faller DV, Rommelaere J, Hopkins N. Large T1 oligonucleotides of Moloney leukemia virus missing in an env gene recombinant, HIX, are present on an intracellular 21S Moloney viral RNA species. Proc Natl Acad Sci U S A. 1978 Jun; 75(6):2964-8.
|
|
|
|
|
195.
|
Faller DV, Hopkins N. T1 oligonucleotide maps of N-, B-, and B leads to NB-tropic murine leukemia viruses derived from BALB/c. J Virol. 1978 Apr; 26(1):143-52.
|
|
|
|
|
196.
|
Faller DV, Hopkins N. T1 oligonucleotides that segregate with tropism and with properties of gp70 in recombinants between N- and B-tropic murine leukemia viruses. J Virol. 1978 Apr; 26(1):153-8.
|
|
|
|
|
197.
|
Faller DV, Hopkins N. RNase T1-resistant oligonucleotides of an N- and a B-tropic murine leukemia virus of BALB/c: evidence for recombination between these viruses. J Virol. 1977 Nov; 24(2):609-17.
|
|
|
|
|
198.
|
Rommelaere J, Faller DV, Hopkins N. RNase T1-resistant oligonucleotides of Akv-1 and Akv-2 type C viruses of AKR mice. J Virol. 1977 Nov; 24(2):690-4.
|
|
|
|
|
199.
|
Faller DV, Hopkins N. RNase T1-resistant oligonucleotides of B-tropic murine leukemia virus from BALB/c and five of its NB-tropic derivatives. J Virol. 1977 Jul; 23(1):188-95.
|
|
|
|
|
200.
|
Fernstrom JD, Hirsch MJ, Faller DV. Tryptophan concentrations in rat brain. Failure to correlate with free serum tryptophan or its ratio to the sum of other serum neutral amino acids. Biochem J. 1976 Dec 15; 160(3):589-95.
|
|
|
|
